Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 1425 participants.

Also called NCT02202434

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 1,425 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT02202434
Other papers using this trial's data
  • Clinical Implications of Physical Function and Resilience in Patients Undergoing Transcatheter Aortic Valve Replacement Journal of the American Heart Association, 2020-09 DOI, PubMed 32856530, PMC7660783 In the PMC Open Access subset under CC BY-NC-ND.
  • Effect of Mechanically Expanded vs Self-Expanding Transcatheter Aortic Valve Replacement on Mortality and Major Adverse Clinical Events in High-Risk Patients With Aortic Stenosis: The REPRISE III Randomized Clinical Trial JAMA, 2018-01-02 DOI, PubMed 29297076, PMC5833545 Not in the PMC Open Access subset.
  • Hemodynamic and Echocardiographic Comparison of the Lotus and CoreValve Transcatheter Aortic Valves in Patients With High and Extreme Surgical Risk: An Analysis From the REPRISE III Randomized Controlled Trial Circulation, 2018-06-12 DOI, PubMed 29530883
  • Long-term Outcomes of Transcatheter Aortic Valve Replacement With the Lotus Valve vs CoreValve/EvolutR: A Secondary Analysis of the REPRISE III Randomized Clinical Trial JAMA network open, 2022-10-03 DOI, PubMed 36301543, PMC9614584 In the PMC Open Access subset under CC BY-NC-ND.
  • Pacemaker Implantation and Dependency After Transcatheter Aortic Valve Replacement in the REPRISE III Trial Journal of the American Heart Association, 2019-11-05 DOI, PubMed 31640455, PMC6898843 In the PMC Open Access subset under CC BY-NC.
  • Two-Year Outcomes After Transcatheter Aortic Valve Replacement With Mechanical vs Self-expanding Valves: The REPRISE III Randomized Clinical Trial JAMA cardiology, 2019-03-01 DOI, PubMed 30810703, PMC6439548 Not in the PMC Open Access subset.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States, Australia, Canada, France, Germany, Netherlands (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02202434. Randomized; no masking; primary purpose treatment. Start 2014-09-22 (actual); primary completion 2017-03-08 (actual). Results posted on 2019-07-30.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Safety and Efficacy Study of Lotus Valve for Transcatheter Aortic Valve Replacement
Acronym
REPRISE III
Condition
Aortic Stenosis
Intervention (Device)
Lotus Valve System
Intervention (Device)
CoreValve/Evolut R Transcatheter Aortic Valve Replacement System
Intervention (Device)
LOTUS Edge Valve System
Lead sponsor
Boston Scientific Corporation (class: industry)

Record details

Record id
cardio:ct-nct02202434
Content hash
490908958bce11f3de022b69ae591c70e1443f6455d9eaa378601a37e87b750d